Rituxan Hycela (rituximab/hyaluronidase human) 1600 mg/13.4 mL Single-Dose Vial **Refrigerated Item**

Rituxan Hycela (rituximab/hyaluronidase human) 1600 mg is used for the treatment of certain types of cancer and autoimmune diseases. It combines rituximab, an antibody targeting CD20-positive B cells, with hyaluronidase to enhance absorption. This formulation is indicated for Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, and certain cases of pemphigus vulgaris. By depleting B cells, it helps reduce disease activity and manage symptoms, offering a more convenient subcutaneous administration compared to intravenous infusions.

Rituxan hycela is a chemotherapy drug that is used to treat a range of cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. It is a monoclonal antibody, which means that it is designed to target and destroy a specific type of cell. Rituxan hycelA works by binding to the surface of cancer cells and destroying them. This can be a very effective treatment for cancer, but it can also cause some side effects, such as nausea and vomiting.

Brand: Genentech USA
NDC: 50242-0109-01
Strength: 1600mg and 26800 Units
Count: 1